FDA approved KERENDIA (finerenone) as the first new treatment in 30 years for adults with chronic kidney disease associated ...

Vera Therapeutics, Inc. ( VERA) reported that in the pivotal ORIGIN 3 trial of TRUTAKNA (atacicept-vymj), an FDA-approved dual BAFF and APRIL inhibitor, it stabilised kidney function and prevented ...

Deals: Apollo Global Management is in negotiations to acquire Johnson & Johnson’s DePuy Synthes orthopedics business in a ...

the curiosity to learn, the willingness to adapt, the courage to be uncomfortable, and the commitment to solve real human problems will define the true technology change-makers ...

Morgan Stanley 24th Annual Global Healthcare Conference September 15, 2026 4:50 PM EDTCompany ParticipantsJennifer Good ...

Officials from the US met Iran-backed, Yemen-based Houthi rebel leaders over the weekend in Oman, which led to Washington's ...

As the U.S. pharmaceutical tariff full-implementation countdown kicks off, 26 pharma enterprises have finished required ...

The U.S. Web Design System is intended to help the federal government build accessible and mobile-friendly websites.

GSK has bet up to $750 million on a Chimagen Biosciences trispecific T-cell engager, positioning the Big Pharma to start ...

Shares rose after strong clinical data strengthened the case for its $10.6 billion Nuvalent acquisition and broader push to rebuild oncology around lung cancer.

GSK is consolidating two of its influenza vaccine manufacturing sites into one, leaving hundreds of jobs at risk.  | GSK is ...